메뉴 건너뛰기




Volumn 35, Issue 1, 2013, Pages 77-81

The relationships between serum sTWEAK, FGF-23 levels, and carotid atherosclerosis in renal transplant patients

Author keywords

Atherosclerosis; FGF 23; Renal transplantation; STWEAK

Indexed keywords

APOPTOSIS INDUCING FACTOR; FIBROBLAST GROWTH FACTOR 23; SOLUBLE TUMOR NECROSIS FACTOR LIKE WEAK INDUCER OF APOPTOSIS; UNCLASSIFIED DRUG;

EID: 84872482341     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2012.734890     Document Type: Article
Times cited : (17)

References (24)
  • 1
    • 80054705417 scopus 로고    scopus 로고
    • Prevention of cardiovascular disease in adult recipients of kidney transplants
    • Jardine AG, Gaston RS, Fellstrom BC, Holdaas H. Prevention of cardiovascular disease in adult recipients of kidney transplants. Lancet. 2011;15(378):1419-1427.
    • (2011) Lancet , vol.15 , Issue.378 , pp. 1419-1427
    • Jardine, A.G.1    Gaston, R.S.2    Fellstrom, B.C.3    Holdaas, H.4
  • 3
    • 77958596052 scopus 로고    scopus 로고
    • InflamM.A.tion, metalloproteinases, and growth factors in the development of carotid atherosclerosis in renal transplant patients
    • Sánchez-Escuredo A, Pastor MC, Bayés B, et al. InflamM.A.tion, metalloproteinases, and growth factors in the development of carotid atherosclerosis in renal transplant patients. Transplant Proc. 2010;42:2905-2907.
    • (2010) Transplant Proc , vol.42 , pp. 2905-2907
    • Sánchez-Escuredo, A.1    Pastor, M.C.2    Bayés, B.3
  • 4
    • 73649148355 scopus 로고    scopus 로고
    • Predictors of carotid artery intiM.A.-media thickness in chronic kidney disease and kidney transplant patients without overt cardiovascular disease
    • YilM.A.z MI, Qureshi AR, Carrero JJ, et al. Predictors of carotid artery intiM.A.-media thickness in chronic kidney disease and kidney transplant patients without overt cardiovascular disease. Am J Nephrol. 2010;31:214-221.
    • (2010) Am J Nephrol , vol.31 , pp. 214-221
    • Yilmaz, M.I.1    Qureshi, A.R.2    Carrero, J.J.3
  • 7
    • 79955566226 scopus 로고    scopus 로고
    • Soluble TWEAK and PTX3 in nondialysis CKD patients: Impact on endothelial dysfunction and cardiovascular outcomes
    • YilM.A.z MI, Sonmez A, Ortiz A, et al. Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes. Clin J Am Soc Nephrol. 2011;6:785-792.
    • (2011) Clin J Am Soc Nephrol , vol.6 , pp. 785-792
    • Yilmaz, M.I.1    Sonmez, A.2    Ortiz, A.3
  • 8
    • 73449115326 scopus 로고    scopus 로고
    • Soluble TWEAK plasM.A. levels as a novel bioM.A.rker of endothelial function in patients with chronic kidney disease
    • YilM.A.z MI, Carrero JJ, Ortiz A, et al. Soluble TWEAK plasM.A. levels as a novel bioM.A.rker of endothelial function in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:1716-1723.
    • (2009) Clin J Am Soc Nephrol , vol.4 , pp. 1716-1723
    • Yilmaz, M.I.1    Carrero, J.J.2    Ortiz, A.3
  • 9
    • 64049100064 scopus 로고    scopus 로고
    • Additive effects of soluble TWEAK and inflamM.A.tion on mortality in hemodialysis patients
    • Carrero JJ, Ortiz A, Qureshi AR, et al. Additive effects of soluble TWEAK and inflamM.A.tion on mortality in hemodialysis patients. Clin J Am Soc Nephrol. 2009;4:110-118.
    • (2009) Clin J Am Soc Nephrol , vol.4 , pp. 110-118
    • Carrero, J.J.1    Ortiz, A.2    Qureshi, A.R.3
  • 10
    • 84872450180 scopus 로고    scopus 로고
    • Soluble TWEAK level is it a M.A.rker for cardiovascular disease in long-term hemodialysis patients?
    • doi:10.5301/jn.5000121
    • Gungor O, Kircelli F, Asci G, et al. Soluble TWEAK level: is it a M.A.rker for cardiovascular disease in long-term hemodialysis patients? J Nephrol. 2012;13. doi:10.5301/jn.5000121
    • (2012) J Nephrol , pp. 13
    • Gungor, O.1    Kircelli, F.2    Asci, G.3
  • 11
    • 65449164651 scopus 로고    scopus 로고
    • A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure
    • Jain M, Jakubowski A, Cui L, et al. A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure. Circulation. 2009;119:2058-2068.
    • (2009) Circulation , vol.119 , pp. 2058-2068
    • Jain, M.1    Jakubowski, A.2    Cui, L.3
  • 12
    • 77958572969 scopus 로고    scopus 로고
    • PlasM.A. fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in M.A.intenance hemodialysis patients
    • Balci M, Kirkpantur A, Gulbay M, Gurbuz OA. PlasM.A. fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in M.A.intenance hemodialysis patients. Hemodial Int. 2010;14:425-432.
    • (2010) Hemodial Int , vol.14 , pp. 425-432
    • Balci, M.1    Kirkpantur, A.2    Gulbay, M.3    Gurbuz, O.A.4
  • 13
    • 77952926817 scopus 로고    scopus 로고
    • Impact of fibroblast growth factor 23 on lipids and atherosclerosis in hemodialysis patients
    • Ashikaga E, Honda H, Suzuki H, et al. Impact of fibroblast growth factor 23 on lipids and atherosclerosis in hemodialysis patients. Ther Apher Dial. 2010;14:315-322.
    • (2010) Ther Apher Dial , vol.14 , pp. 315-322
    • Ashikaga, E.1    Honda, H.2    Suzuki, H.3
  • 16
    • 4744343528 scopus 로고    scopus 로고
    • Proliferation of neointimal smooth muscle cells after arterial injury: Dependence on interactions between fibroblast growth factor receptor-2 and fibroblast growth factor-9
    • DOI 10.1074/jbc.M408121200
    • Agrotis A, Kanellakis P, Kostolias G, et al. Proliferation of neointiM.A.l smooth muscle cells after arterial injury. Dependence on interactions between fibroblast growth factor receptor-2 and fibroblast growth factor-9. J Biol Chem. 2004;279:42221-42229. (Pubitemid 39313671)
    • (2004) Journal of Biological Chemistry , vol.279 , Issue.40 , pp. 42221-42229
    • Agrotis, A.1    Kanellakis, P.2    Kostolias, G.3    Di Vitto, G.4    Wei, C.5    Hannan, R.6    Jennings, G.7    Bobik, A.8
  • 17
    • 0034835346 scopus 로고    scopus 로고
    • Modulation of smooth muscle proliferation in rat carotid artery by platelet-derived mediators and fibroblast growth factor-2
    • DOI 10.1080/09537100120071013
    • Lewis CD, Olson NE, Raines EW, Reidy M.A., Jackson CL. Modulation of smooth muscle proliferation in rat carotid artery by platelet-derived mediators and fibroblast growth factor-2. Platelets. 2001;12:352-358. (Pubitemid 32896892)
    • (2001) Platelets , vol.12 , Issue.6 , pp. 352-358
    • Lewis, C.D.1    Olson, N.E.2    Raines, E.W.3    Reidy, M.A.4    Jackson, C.L.5
  • 18
    • 77958586959 scopus 로고    scopus 로고
    • Increased expression of bFGF is associated with carotid atherosclerotic plaques instability engaging the NF-κB pathway
    • Sigala F, Savvari P, LiontosM, et al. Increased expression of bFGF is associated with carotid atherosclerotic plaques instability engaging the NF-κB pathway. J Cell MolMed. 2010;14:2273-2280.
    • (2010) J Cell Mol Med , vol.14 , pp. 2273-2280
    • Sigala, F.1    Liontosm, S.P.2
  • 19
    • 78549244818 scopus 로고    scopus 로고
    • New insights into the role of fibroblast growth factor 23 in chronic kidney disease
    • Nakai K, KoM.A.ba H, Fukagawa M. New insights into the role of fibroblast growth factor 23 in chronic kidney disease. J Nephrol. 2010;23:619-625.
    • (2010) J Nephrol , vol.23 , pp. 619-625
    • Nakai, K.1    Komaba, H.2    Fukagawa, M.3
  • 20
    • 0038320242 scopus 로고    scopus 로고
    • TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor
    • DOI 10.1016/S1359-6101(03)00019-4
    • Wiley SR, Winkles JA. TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TWEAKR/Fn14 receptor. Cytokine Growth Factor Rev. 2003;14:241-249. (Pubitemid 36693144)
    • (2003) Cytokine and Growth Factor Reviews , vol.14 , Issue.3-4 , pp. 241-249
    • Wiley, S.R.1    Winkles, J.A.2
  • 21
    • 36049022442 scopus 로고    scopus 로고
    • TWEAKing tissue remodeling by a multifunctional cytokine: Role of TWEAK/Fn14 pathway in health and disease
    • DOI 10.1016/j.cyto.2007.09.007, PII S1043466607004164
    • Burkly LC, Michaelson JS, Hahm K, Jakubowski A, Zheng TS. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease. Cytokine. 2007;40:1-16. (Pubitemid 350088500)
    • (2007) Cytokine , vol.40 , Issue.1 , pp. 1-16
    • Burkly, L.C.1    Michaelson, J.S.2    Hahm, K.3    Jakubowski, A.4    Zheng, T.S.5
  • 22
    • 73849087983 scopus 로고    scopus 로고
    • Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal daM.A.ge induced by hyperlipidemic diet in ApoE-knockout mice
    • Muñoz-García B, Moreno JA, López-Franco O, et al. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal daM.A.ge induced by hyperlipidemic diet in ApoE-knockout mice. Arterioscler Thromb Vasc Biol. 2009;29:2061-2068.
    • (2009) Arterioscler Thromb Vasc Biol , vol.29 , pp. 2061-2068
    • Muñoz-García, B.1    Moreno, J.A.2    López-Franco, O.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.